60 Degrees Pharmaceuticals (SXTP) Earnings Date, Estimates & Call Transcripts $2.22 -0.30 (-11.90%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 60 Degrees Pharmaceuticals Earnings Summary 60 Degrees Pharmaceuticals issued Q1 2025 earnings on May 15, 2025, reporting an EPS of -$1.56, which missed the consensus estimate of -$1.31 by $0.25. Quarterly revenue was reported to be $0.18 million, above analysts' expectations of $0.15 million. With a trailing EPS of -$50.41, 60 Degrees Pharmaceuticals' earnings are expected to grow next year, from ($5.09) to ($0.61) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 15) -$1.31 Actual EPS (May. 15) -$1.56 Missed By -$0.25 Actual Revenue (May. 15) $0.18MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q)SXTP Upcoming Earnings60 Degrees Pharmaceuticals' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get 60 Degrees Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 60 Degrees Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSXTP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SXTP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. 60 Degrees Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$2.81-$2.81-$2.81Q2 20252-$1.24-$1.18-$1.21Q3 20252-$1.21-$0.74-$0.98Q4 20252-$1.12-$0.53-$0.83 FY 2025 7 -$6.38 -$5.26 -$5.82 Q1 20261-$1.32-$1.32-$1.32Q2 20261-$1.30-$1.30-$1.30Q3 20261-$1.39-$1.39-$1.39Q4 20261-$1.35-$1.35-$1.35 60 Degrees Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$1.31-$1.56 -$0.25-$1.56$0.15M$0.18M8/14/2024Q2 2024-$13.95-$21.15 -$7.20-$4.23$0.11M$0.13M5/15/2024Q1 2024-$0.80$0.15+$0.95$0.03-$0.08M4/1/2024Q4 2023--$2.20--$0.44$0.06M-$0.10M11/20/2023Q3 2023-$1.30-$1.50 -$0.20-$1.37$0.08M$0.06M8/25/2023Q2 2023--$7.00--$1.40-$0.06M 60 Degrees Pharmaceuticals Earnings - Frequently Asked Questions When is 60 Degrees Pharmaceuticals' earnings date? 60 Degrees Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on SXTP's earnings history. Did 60 Degrees Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, 60 Degrees Pharmaceuticals (NASDAQ:SXTP) missed the analysts' consensus estimate of ($1.31) by $0.25 with a reported earnings per share (EPS) of ($1.56). Learn more on analysts' earnings estimate vs. SXTP's actual earnings. How much revenue does 60 Degrees Pharmaceuticals generate each year? 60 Degrees Pharmaceuticals (NASDAQ:SXTP) has a recorded annual revenue of $665,452.00. How much profit does 60 Degrees Pharmaceuticals generate each year? 60 Degrees Pharmaceuticals (NASDAQ:SXTP) has a recorded net income of -$7.95 million. SXTP has generated -$50.41 earnings per share over the last four quarters. What is 60 Degrees Pharmaceuticals' EPS forecast for next year? 60 Degrees Pharmaceuticals' earnings are expected to grow from ($5.09) per share to ($0.61) per share in the next year. More Earnings Resources from MarketBeat Related Companies Edesa Biotech Earnings Results Bullfrog AI Earnings Results Synlogic Earnings Results Rallybio Earnings Results AlloVir Earnings Results Flora Growth Earnings Results Imunon Earnings Results TherapeuticsMD Earnings Results 23andMe Earnings Results Ernexa Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s Next This page (NASDAQ:SXTP) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SXTP Stock Alerts